ML Randi, E Ruzzon, G Luzzatto, F Tezza, A Girolami, F Fabris. Safety profile of hydroxyurea in the treatment of patients with Philadelphia-negative chronic myeloproliferative disorders. haematol [Internet]. 2005Feb.1 [cited 2024Nov.26];90(2):261-2. Available from: https://haematologica.org/article/view/3393